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A method for analysis of 7a-hydroxy-4-cholesten-3-one in plasma is described. Following solid-phase extraction/purifica- 
tion the compound isdetermined by high-performance liquid chromatography using a UV detector. The median concen- 
tration in healthy subjects was 12 ng/ml (range 3-W). The levels were lower in diseases associated with a low bile acid 
production: extrahepatic cholestasis, < 1.5 ng/ml (range < 0.9-3); liver cirrhosis < 1.5 ng/ml (range < 0.9-38), and higher 
in diseases associated with a high bile acid production: cholestyramine treatment, 188 ng/ml (range 54477); ileal resection 
397 ng/ml (range 128-750). The levels were essentially normal in patients with colon resection. The results are consistent 
with a strong positive correlation between the levels of 7a-hydroxy-4-cholesten-3-one in plasma and the rate of bile acid 
synthesis. 
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1. INTRODUCTION 
The development of cardiovascular disease is 
positively correlated to the levels of cholesterol in 
plasma [ 11. Among factors regulating this level are 
the rates of synthesis and removal of cholesterol. 
Formation of bile acids constitutes a major 
pathway of elimination [2]. Rates of bile acid syn- 
thesis in vivo may be determined by isotope dilu- 
tion methods or analysis of fecal bile acid 
excretion. Relative rates may also be evaluated in 
vitro by determination of cholesterol 7a- 
hydroxylase [3,4]. Recently the levels of 7~ 
hydroxycholesterol in plasma were found to cor- 
relate positively to the activity of the 7~ 
hydroxylase in cases with increased bile acid syn- 
thesis [5,6]. In the course of studies on sterols and 
bile acids in plasma, the levels of 705 
hydroxy-4-cholesten-3-one, the next intermediate 
in bile acid biosynthesis, were found to be in- 
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creased in patients with ileal resection, a condition 
in which bile acid production is increased. This 
paper describes a simple liquid-chromatographic 
method for the analysis and reports on the concen- 
trations of 7a-hydroxy-4-cholesten-3-one in 
plasma from patients with diseases known to be 
associated with an abnormal bile acid production. 
The results are consistent with a strong positive 
correlation between the levels of the sterol in 
plasma and the rate of bile acid biosynthesis. 
2. MATERIALS AND METHODS 
2.1. Patients 
Blood was obtained from patients with liver diseases, in- 
testinal diseases or under treatment with cholestyramine. The 
patients were divided into the following groups. (A) Three men 
and eight women, 50-87 years old (median age 69), with large 
bile duct obstruction secondary to carcinoma or gallstones and 
with grossly elevated bile acid levels in blood. (B) Five men and 
three women, 54-60 years old (median age 58), with moderate 
or severe forms of alcoholic liver cirrhosis. (C) Two men and 
eleven women, 41-75 years old (median age 65), with primary 
biliary cirrhosis. The diagnosis of patients in groups B and C 
was made on the basis of full clinical and chemical investigation 
including liver biopsy. Most of these patients had elevated levels 
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of bile acids in blood. (D) Three men and three women, 28-50 
years old (median age 37), subjected to a complete colectomy 
due to polyposis coli. One patient had ileostomy whereas the 
others had an ileo-rectal anastomosis. (E) One man and seven 
women, 39-X years ~$6 (metian age 62) with ~>PEJ- 
cholesterolemia and treated with 8 g cholestyramine 
(Questran@ , Bristol) twice daily for 6-8 weeks prior to sampl- 
ing. [F) Two men ana three women, 38-59 years old \mecYlan 
age 39), subjected to a resection of terminal ileum (>60 cm) 
with or without hemicolectomy. (G) Two men, 38 and 42 years 
old, s&&d -tn P r-se_?i-Jr, -d -mmim: Ghm C_; -Nit1 ~m2, .zd 
the entire colon. jH)Two men and one woman, ages 32,43 and 
50 ye&K?, r%i?&&e@, s&j-_,,, flt& <a & r%X&?s% Gf &re &Xrmi~.a.l 
ileum (> 100 cm) and the entire colon. The patients in groups 
F-H had Crohn’s disease. The operations were performed 
more than 2 years before this investigation. 
2.2. Control material 
Blood from 20 apparently healthy men and women, 21-48 
years dd (median age 37) was cokcted in tubes with or witbout 
heparin. Following centrifugation, plasma/serum was 
separated and stored at -20°C until analyzed. All subjects 
were not fasting, but most samples were collected in the 
morning. 
2.3. Glassware and chemicals 
All glassware was silanized and cleaning was carried out in an 
ultrasonic bath. Solvents were of analytical reagent grade. 7a- 
Hydroxy-4-cholesten-3-one and 25-hydroxyvitamin D3 were 
kind gifts from Professor I. Bjbrkhem, Huddinge Hospital and 
Roche-Produkter, Sweden, respectively. 25_Hydroxy[26,27- 
methyl-‘HIvitamin D3 (176 CVmmol) was from the Radio- 
chemical Centre (Amersham, England) and radioactivity was 
determined in an LKBIWaRac 1215 Rackbeta scintillaGon 
courter wjtii Picofluor as r%e scinfjZation liquid. Oc~adecy~- 
silane (ODS)-bonded silica (Preparative C18, particle size 
55-105 pm) was from Waters Associates (Milford, MA). Col- 
umn beds (1.0 x 0.8 cm, dry wt about 0.34 g) of this material 
wer~.Dr~Dareb’In:,ackereb~lass ccjmmns connecleb ‘lo a waler 
bath and equipped with gauze-covered valves of Teflon. The 
sorbent was washed with 5 ml each of methanol, methanol/ 
chloroform (1 : 1, v/v), methanol and water prior to use. Ap- 
prolp&re ‘TIOW rates were dbra’meb ‘oy ap#ixXixm UT ritrzvmn 
pressure. 
2.4. Analytical procedure (see also 171) 
Following addition of ‘H-labelled 25-hydroxyvitamin D3 
(abcotil NV& cPn;,, $asma OT serum )usuaU1y Z Kiowas Mni\%b 
with 2 vols isotonic saline (when bile acids were also to be 
anaIyzed, 0.25 M aqueous triethylamine sulphate, pH -7, was 
used insyeah 05 saY>ne 1%)). The s&nilon wab ‘ne~\~~% 6V C 50~ 
5 min and then extracted on the column of ODS-bonded silica 
at the same temperature (flow rate about 1 ml/minj. The col- 
umn was washed with 10 ml water (at 64°C) and 10 ml of 65% 
aqueous methanol (at room temperature). Prior to elution of 
steroids with 8 ml hexane/chloroform (95 : 5, v/v) or 6 ml hex- 
ane/chloroform (1: 1, v/v), a gentle stream of nitrogen was 
passed through the column for 0.5 min. The eluate, collected in 
a stoppered tube, was then taken to dryness under a stream of 
nitrogen and the residue was redissolved in 0.1 ml hexane. 
2.5. High-performance liquid chromatography (HPLC) and 
gas chromatography-mass spectrometry (GCIMS) 
HPLC was carried out on a column (250 x 4.5 mm) of 
LiChrospher (Hibar, Si 100, 5 pm, Merck-Darmstadt) con- 
nect& to a pump $Constam&c 111) and a fixed-waVelen& 
(254 nm) detector (LDC/Milton Roy, Riviera Beach, FL). The 
mobile phase was hexane/isopropano1(95 : 5, v/v). The amount 
of 7ru-hydroxy-4-cholesten-3-one in plasma was aeterrrimea by 
comparing its peak area with that of known amounts of the 
reference compound. Since a radioactive version was not 
~c~i&~~, -Q:>&&*’ ?4 U ~J-+ry&,-~*~~v?;7mriTL -3, ) ?iikkd-~L*ir, -PI‘ix- 
traction and determined in the effluent from the H’PZC co)- 
‘ammo, ‘X7.4& c0 cG7r<zX F% ‘RSYZS zrd differ-,zcs in 18*.&N& 
volumes. The extraction yield and polarity of 
25.hydroxyvitamin Dj were very similar to those of SLY- 
hydroxy-4-cholesten-3-one (see section 3). The molar response 
of 7a-hydroxy-4-cholesten-3-one at 254 nm was 0.33-0.40 
relative to that of 25-hydroxyvitamin D3 in the system used. For 
identification purposes, the HPLC column was connected to a 
Waters 990, photo&de array detector (Waters Associates) 
monitoring wavelengths from 220 to 300 nm. GUMS analyses 
of trimethylsilyl ether derivatives 191 were performed on a Fin- 
nigan 1020 instrument housing a fused-silica column (30 m x 
0.32 mm) caated with SE-3Q D&l 191. The CQntitiQns were 
those used in previous studies [9] and repetitive scanning cover- 
ing the m/z range 50-800 was started after suitable delay. 
3. RESULTS AND DISCUSSION 
3.1 Analysis of 7a-hydroxy-4-cholesten-3-one 
The analytical method is essentially that de- 
scribed previously for analysis of 2%hydroxyvita- 
min D3 [7]. When levels of the latter were studied 
in patients with smaH bowel resection, a large peak 
of an unknown compound was observed (fig.1). 
Analyses using the photodiode array detector 
showed an absorption maximum at about 240 nm. 
L’wfl GJX a~-& G%4PS L!I+~ r&efl&fl iflc?eX 
(Kovats) of the trimethylsilyl derivative on a 
methyl silicone column was 3233 and the mass 
3~*l-i-ml -s?lUW& a -tno’mdat km -21 WL~_z G-n mdl 
fragment ions typical of the derivative of 7cu- 
hydroxy-4-cholesten-3-one [9- 111. This identifica- 
tion was confirmed by comparison with the 
a!utt?.e&ic QX!XqQu-d. 
The HPLC method is simple compared to 
anaIysis by selected ion monitoring GCYMS [ll]. 
HPLC is pcee&e& & a single 50&e& ex&ac- 
tion/purification step. Protein binding of the 
steroids is counteracted by dilution of the 
plasma/serum with saline [7,8,12] or triethylamine 
sulphate [8] and performing the extraction at 64°C 
[7,12]. Under these conditions polar material as 
well as most (> 80-90%) of the hydrophobic lipids 
(e.g. cholesterol) are not sorbed. Recoveries of 
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Fig. 1. HPLC analyses of 7Lu-hydroxy-4-cholesten-3-one (C4) in 
plasma from (I) a 69-year-old woman with primary biliary 
cirrhosis and (II) a 50-year-old woman with resection of about 
2 m terminal ileum and the entire colon. The equivalents of 
about 400 pl (I) and 200 gl (II) of plasma were injected and the 
concentrations of the compound were < 1 ng/ml (I) and 
732 ng/ml (II). The peaks dl and ds represent 
25hydroxyvitamin Dz and 25hydroxyvitamin D3, respectively. 
The concentrations of the latter compound were 2.4 ng/ml (I) 
and 21 ng/ml (II). Both patients were treated with vitamin D. 
added 7cu-hydroxy-4-cholesten-3-one (table 1) were 
essentially quantitative, i.e. like those of 25hy- 
droxyvitamin D3 reported previously [7]. Thus, 
commercially available 3H-labelled 25hydroxy- 
vitamin D3 could be used to correct for losses and 
variations in injection volumes. Extraction yields 
were the same whether saline or aqueous triethyl- 
amine sulphate was used as diluent. The latter has 
to be used for quantitative extraction of bile acids 
[9]. Although labile in acidic and alkaline solu- 
tions, the 7a-hydroxy-A4-3-oxo structure was 
stable under the conditions of the analytical 
method. In contrast to 7a/,&hydroxy-, 7-0x0-, 
25hydroxy- and other oxygenated forms of 
cholesterol, 7c+hydroxy-4-cholesten-3-one is not 
formed as an artefact from cholesterol [ 131. Thus, 
the problems encountered in analysis of SLY- 
hydroxycholesterol are avoided. The absence of 
artefactual formation is supported by the very low 
levels found in some patients. 
The precision of the method was evaluated by 
analysis of 8 samples from the same plasma pool. 
The coefficient of variation was about 5% at a 
concentration of about 25 ng/ml plasma. The 
detection limit was usually about 0.5-1.5 ng/ml. 
If necessary, this could be lowered by increasing 
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Table 1 
Precision and recoveries in the analysis of 7a- 
hydroxy-4-cholesten-3-one 
7Lu-Hydroxy-4-cholesten-3-one in 2 ml plasma 
Amount added Amount measured 
(ng) (ng) 
0 48.8 * 2.6b 
13 62 
31 80 
62 100 
110 163 
540 621 
1100 1045 
5400 5144 
a Per cent of added amount 
b Mean + SD, CV = 5% 
Recovery 
(Q) 
_ 
100 
100 
82 
104 
106 
91 
94 
A pool containing plasma from 20 subjects was analyzed eight 
times. Recoveries were determined after addition of the 
compound to 2-ml samples prior to extraction 
the volume of plasma used (sorbent capacity about 
10 ml plasma) and optimizing the HPLC condi- 
tions. A variation of the retention time relative to 
25-hydroxyvitamin D3 (usually about I .l) was 
sometimes observed depending on solvent com- 
position and column conditions. In the present 
form the method is about lo-times more sensitive 
than the reported GUMS procedure [l 11. The 
analysis requires no specialized instrumentation 
and a technician can readily analyze lo- 15 samples 
in a day. 
3.2. Concentrations of 7cu-hydroxy-4-cholesten-3- 
one in plasma 
The occurrence of 7Lu-hydroxy-4-cholesten-3- 
one in liver and plasma at levels of 50 f 10 ng/ml 
plasma in healthy subjects has been reported by 
Bjorkhem et al. [lo, Ill. When we found highly 
elevated levels in patients with ileal resection, a 
possible relationship to the increased bile acid syn- 
thesis in these patients [14] was suspected. To test 
this hypothesis, the concentrations of 7a-hydroxy- 
4-cholesten-3-one were measured in plasma from 
patients with diseases known to be associated with 
increased or decreased bile acid production. The 
results are shown in fig.2. Healthy controls usually 
had levels between 6 and 30 ng/ml (median 12 ng/ 
ml, range 3-40 ng/ml). A possible sex difference 
(fig.2) was not statistically significant. The highest 
number 2 FEBS LETTERS November 1988 
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Fig.2. Concentrations of 7cu-hydroxy-4-cholesten-3-one in plasma from patients belonging to groups known to have a decreased 
(groups A-C; liver diseases) or increased (groups E-H; cholestyramine, ileal resection) production of bile acids. Group D included 
patients with resection of the entire colon. For patient classification see section 2. The concentration range between 6 and 30 ng/ml 
was arbitrarily used to represent values for healthy subjects. The values are transformed to nmol/l by multiplication with 2.5. 
levels were seen in patients with ileal resection (me- 
dian 397 ng/ml, range 128-750 ng/ml) who have a 
defective feed-back inhibition of the bile acid syn- 
thesis due to inefficient reabsorption of bile acids 
[ 141. Patients treated with cholestyramine, also af- 
fecting bile acid reabsorption, all had high concen- 
trations (median 188 ng/ml, range 54-477 ng/ml), 
supporting the conclusion that interference with 
bile acid absorption and not removal of ileum per 
se affects the concentration of 7@-hydroxy-4- 
cholesten-3-one. 
As shown in fig.2 the levels of ICY- 
hydroxy-4-cholesten-3-one in patients with ileal 
resection depended on the presence or absence of 
colon. Thus, the levels were lower (median 
195 ng/ml, range 128-370 ng/ml) when half of 
the colon was intact than when a shorter part of il- 
eum but the entire colon had been removed (me- 
dian 600 ng/ml, range 424-750 ng/ml). Patients 
with an intact ileum had essentially normal levels 
also in the absence of a colon (median 24 ng/ml, 
range 4-64 ng/ml). Taken together, these results 
indicate that reabsorption of bile acids from colon 
plays an important role in patients with ileal resec- 
tion but is of minor importance under normal con- 
ditions. 
Patients with extrahepatic cholestasis and cir- 
rhosis, conditions associated with a decreased bile 
acid production [ 151, in most cases had very low 
levels of 7a-hydroxy-4-cholesten-3-one (median 
< 1.5 ng/ml; figs 1,2). This indicates that when its 
rate of formation is low, there is no accumulation 
of this steroid in blood. A 2-year-old boy with cir- 
rhosis and ileal resection had greatly elevated levels 
(249 ng/ml) in agreement with the hypothesis that 
the decreased bile acid production in cirrhosis is 
due to bile acid-induced inhibition of cholesterol 
7a-hydroxylase and not to a decreased amount of 
liver tissue. 
7a-Hydroxy-4-cholesten-3-one has previously 
been determined in patients with cerebrotendinous 
xanthomatosis [ 111. These patients lack the normal 
feed-back inhibition of bile acid formation because 
of a defect in the side chain hydroxylation required 
for normal bile acid formation [2,16-181. The 
levels of 7cY-hydroxy-4-cholesten-3-one w re ex- 
tremely high (4500-8500 ng/ml). While this may 
be due to an accumulation secondary to the lack of 
mitochondrial 26-hydroxylase [ 171, an increased 
formation due to the absence of feed-back inhibi- 
tion may be an additional reason. 
Many factors will determine the levels of ICY- 
hydroxy-4-cholesten-3-one in plasma. It is 
reasonable to assume that the rate of formation is 
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one determinant. The rate-limiting step in bile acid 
biosynthesis is the 7cu-hydroxylation of cholesterol 
[2]. When the rate of this reaction increases, there 
will also be an increased formation of 7a- 
hydroxy-4-cholesten-3-one. Unless 12a-hydroxy- 
lated, this intermediate will leave the endoplasmic 
reticulum for subsequent metabolic transforma- 
tions [2]. It is reasonable to assume that the 
leakage to plasma can increase when the rate of 
formation is increased. A rate limitation of the S/3- 
reduction or 26-hydroxylation cannot be excluded. 
A similar explanation has been given for the 
paradoxical increase of 7cu-hydroxycholesterol in 
plasma when the activity of cholesterol 7a- 
hydroxylase is increased [5]. 
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